Argus Investors' Counsel, Inc. Boston Scientific Corp Transaction History
Argus Investors' Counsel, Inc.
- $148 Million
- Q3 2024
A detailed history of Argus Investors' Counsel, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Argus Investors' Counsel, Inc. holds 26,795 shares of BSX stock, worth $2.43 Million. This represents 1.52% of its overall portfolio holdings.
Number of Shares
26,795
Previous 20,174
32.82%
Holding current value
$2.43 Million
Previous $1.55 Million
44.56%
% of portfolio
1.52%
Previous 0.97%
Shares
3 transactions
Others Institutions Holding BSX
# of Institutions
1,542Shares Held
1.19BCall Options Held
6.79MPut Options Held
10.1M-
Vanguard Group Inc Valley Forge, PA131MShares$11.9 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY126MShares$11.5 Billion0.22% of portfolio
-
State Street Corp Boston, MA62.8MShares$5.7 Billion0.22% of portfolio
-
Primecap Management CO Pasadena, CA37.8MShares$3.43 Billion2.37% of portfolio
-
Wellington Management Group LLP Boston, MA32.8MShares$2.98 Billion0.49% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $130B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...